Xencor | XNCR - Market Capitalization


Xencor reported $732.8M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 371.63B 37.4B Feb/2026
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Arrowhead Research USD 4.77B 2.59B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Cytokinetics USD 6.58B 2.63B Sep/2025
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 837M 278M Sep/2025